MIAMI, June 30, 2022 (GLOBE NEWSWIRE) -- Neocis®, manufacturer of Yomi® and the global leader in robot-assisted dental implant surgery, announced today that their latest software offering, YomiPlan Go™, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) after the successful completion of a recent clinical study. This marks the 13th FDA clearance Neocis has received to date.
Yomi, the first and only FDA-cleared robotic system for dental surgery, assists clinicians in both planning and operative phases of dental implant placement via interactive digital planning (using YomiPlan™ software) and robotic guidance of surgical instrumentation, respectively.
YomiPlan Go, which is expected to be commercially available later this summer, is a software-based workflow that allows doctors to directly visualize a patient’s anatomy, set the desired location and angulation of an implant using their drill tip, and then perform an osteotomy under robotic guidance. This mode differs from the platform’s other workflow options (YomiPlan Complete™ and YomiPlan Dynamic™) as it frees clinicians from having to take a CT scan for case planning in YomiPlan, allowing them to get underway with surgery faster.
“This new FDA-cleared workflow demonstrates our commitment to continuous innovation,” said Alon Mozes, Neocis Co-founder and CEO. “We are dedicated to providing all of our partners with versatile solutions that allow them to use Yomi for the wide variety of clinical cases they take on every day.”
YomiPlan Go’s fast, flexible workflow is similar to freehand surgery but offers the enhanced precision and repeatability of robotic assistance. In this mode, Yomi’s guide arm stabilizes the drill, maintains positional and angular precision as the clinician changes bits, and prevents overdrilling. Users can also accurately parallelize multiple fixtures by using the initial implant as a reference point.
"By combining the feel of freehand surgery with the advantages of haptic guidance, YomiPlan Go adds a human touch to robotic implant placement,” said Massachusetts-based general dentist Dr. Sathish Palayam. “It’s as simple as point and place.”
The growing YomiPlan software suite gives dental practices the flexibility to choose a robotic workflow that best fits their needs, so they can perform robot-assisted surgery with minimal disruption to their existing clinical processes and techniques. “We’re thrilled to introduce another innovation that directly resulted from our users’ input,” said Wayne Craig, Chief Commercial Officer at Neocis. “I’ve never been with a company that so closely partners with and listens to its clients to develop innovative, solution-oriented offerings. We’re excited to provide freehand surgeons with a more precise and versatile alternative to this method, without sacrificing speed and clinical efficiency.”
Neocis continues to advance implant dentistry, having secured more than 40 patents since the company’s founding. Earlier this year, Neocis released its latest software update, YomiPlan 2.3, which includes YomiPlan Dynamic–a CT-based workflow that allows clinicians to plan a case intra-operatively using just a day-of scan.
About Yomi Yomi is a computerized robotic navigational system intended to provide assistance in both the planning (pre-operative) and the surgical (intra-operative) phases of dental implantation surgery. The system provides software to preoperatively plan dental implantation procedures and provides robotic navigational guidance of the surgical instruments. Yomi is intended for use in partially edentulous and fully edentulous adult patients who qualify for dental implants.
Since 2016, Yomi has been helping clinicians around the country plan and place dental implants with a high level of precision and efficiency, so they can operate with confidence, expand their implant practice, and deliver an excellent patient experience. The platform has assisted in the placement of more than 13,000 implants. Visit neocis.com to learn more about Yomi or schedule a hands-on demo.
About Neocis Neocis is transforming dental surgery with advanced robotics. The company collaborates closely with leading clinicians to develop innovative technologies that help advance patient care and improve quality of life. Based in Miami, Neocis is venture-backed with funding from DFJ Growth, Mithril Capital Management, Norwest Venture Partners, Vivo Capital, Section 32, and surgical robotics pioneer Fred Moll. For more information, visit neocis.com.
Contact Laura Powell Marketing Manager - Robotics Practice Growth 305-912-4822 info@neocis.com
Bitcoin mining difficulty dropped by 5.01% on Friday, marking the third decline in a row and the largest fall since July 2021, according to data from BTC.com. See related article: Celsius Network could add to crypto mining struggles Fast facts The mining difficulty reading is now at 27.69 trillion at a block height of 745,920, […]
The deal marks one of Amazon's most high-profile pushes into health care to date.
The Finnish telecom company said sales of its telecommunications equipment surged in North America and its efforts to rebound from the missteps of recent years show signs of success.
Tudor Dixon, a conservative commentator, is vying for the chance to take on Michigan Gov. Gretchen Whitmer (D).
Yahoo Finance's Anjalee Khemlani discusses Amazon's acquisition of primary health care provider One Medical and the implications of the merger for patients and the industry.
The technology sector is composed of businesses that sell goods and services in electronics, software, computers, artificial intelligence (AI), and other industries related to information technology (IT). The sector includes companies with the largest market capitalizations in the world, such as Apple Inc., Microsoft Corp., and Amazon.com Inc. Tech stocks, represented by the Technology Select Sector SPDR Fund (XLK), have slightly outperformed the broader market over the past year.
Amazon's health care expansion plans, including its $3.9 billion acquisition of One Medical, shook health care stocks.
Marlena Stell's happiness turned to heartbreak after she found out about nine and a half weeks into her pregnancy that she had suffered a miscarriage. After she was told last year that the fetus did not have a heartbeat and she no longer had a viable pregnancy, the Texas woman asked her doctor to perform a dilation and curettage, or D and C - a standard procedure to remove the fetus following a miscarriage, to help prevent infection or long-term health problems. Stell had the procedure after her
A surgical team led by Dr Tim Forgan uses the da Vinci Xi robot to assist in removing a cancerous rectal tumour from a female patient at Tygerberg public hospital in Cape Town, South Africa. The robot, which has four 'arms' and is controlled in real time by Forgan via an immersive 3D consul, is the most advanced surgical robot in Africa. It is one of only two such robots in use on the continent, both of them found in South African public hospitals in Cape Town.
Yahoo Finance tech reporter Dan Howley outlines how fatal heat waves in the UK, Europe, and U.S. are impacting cloud services and personal tech devices.
Activist Jason Hershey reads from a Bible as he protests in front of the U.S. Supreme Court with the anti-abortion group Bound for Life in 2005 in Washington, D.C. Win McNamee via Getty ImagesIn the days since the Supreme Court overturned Roe v. Wade, which had established the constitutional right to an abortion, some Christians have cited the Bible to argue why this decision should either be celebrated or lamented. But here’s the problem: This 2,000-year-old text says nothing about abortion. As
Anurag Malani, MD, Infectious Disease Lead for COVID-19 Response at Trinity Health Michigan talks about the omicron subvariant BA.5 this summer and monkeypox.
Rebel Wilson just took her IG followers through a day at the wellness retreat, VivaMayer. It's famous among celebrities and helped Rebel with her weight loss.
The best cybersecurity stocks to own are changing amid a shift to remote work and cloud security. Now ransomware attacks are impacting budgets.
Ionis' (IONS) partner, Novartis completes enrolling patients in a phase III study on pelacarsen for treating cardiovascular disease due to elevated Lp(a) levels. Data from this study is expected in 2025.
BA.5 is changing the game when it comes to multiple COVID-19 infections. This is what experts know about how long immunity lasts now.
The Boston biotech is concentrating its work into a handful of focus areas, including a drug intended to treat WHIM syndrome.
An AAA study of U.S. drivers shows that many drive after taking potentially impairing medications on a regular basis.
Without obvious signs of contamination like the mold in this jam, consumers use expiration dates to decide whether to keep or throw away food. Ralf Geithe via iStock/Getty ImagesFlorida’s outbreak of listeria has so far led to at least one death, 22 hospitalizations and an ice cream recall since January. Humans get sick with listeria infections, or listeriosis, from eating soil-contaminated food, undercooked meat or dairy products that are raw, or unpasteurized. Listeria can cause convulsions, c
Apple settles lawsuit over its reviled 'butterfly' keyboard for $50 million, Demand for the Justice League 'Snyder Cut' was reportedly amplified by bots, Judge grants Twitter an expedited trial against Elon Musk.